RNF213 p.R4810K 与颅外颈动脉疾病的独立关联
校正血管危险因素和颅内动脉粥样硬化后,该变异与颅外颈动脉疾病独立相关(OR 1.69,95%CI 1.29-2.22),且关联随狭窄严重程度递增,闭塞的效应估计最大(OR 4.55,95%CI 2.81-7.38)。
要点
- RNF213 p.R4810K变异与颅外颈动脉疾病独立相关,校正颅内动脉粥样硬化后仍显著。
- 关联强度随颅外颈动脉狭窄严重程度递增,闭塞时效应最大。
- 该关联不受颅内动脉粥样硬化状态影响(异质性P=0.32)。
核心结论
- RNF213 p.R4810K变异与颅外颈动脉疾病独立于颅内动脉粥样硬化相关,且呈分级关联。
主要发现
- 携带RNF213 p.R4810K变异者359例(2.6%),颅外颈动脉疾病(≥50%狭窄或闭塞)者2181例(15.6%),其中变异携带者78例。
- 校正血管危险因素和颅内动脉粥样硬化后,变异携带者颅外颈动脉疾病的比值比为1.69(95%CI 1.29-2.22)。
- 该关联与颅内动脉粥样硬化状态无关(异质性P=0.32)。
- 严重程度分析中,关联随颅外颈动脉疾病严重程度逐步增强,闭塞的效应估计最大(比值比4.55,95%CI 2.81-7.38)。
临床怎么用
- 对携带RNF213 p.R4810K变异的卒中或短暂性脑缺血发作患者,应关注颅外颈动脉狭窄评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The RNF213 p.R4810K variant, a susceptibility variant for moyamoya disease, has also been linked to intracranial atherosclerotic disease (ICAD). However, its association with extracranial carotid artery disease (ECAD), particularly whether this association is independent of concomitant ICAD and whether it differs by stenosis severity, remains unclear. METHODS: We conducted a multicenter registry-based observational study of patients with acute ischemic stroke (AIS) or transient ischemic attack enrolled in the Fukuoka Stroke Registry. Patients were genotyped for RNF213 p.R4810K and classified as noncarriers (G/G) or variant carriers (G/A or A/A). ECAD was defined as ≥50% stenosis or occlusion of the extracranial carotid arteries. Multivariable logistic regression was used to assess the association between RNF213 p.R4810K and ECAD after adjusting for vascular risk factors and ICAD, and stratified analyses were performed by ICAD status. ECAD severity was modeled ordinally (none, moderate, severe, and occlusion) using a partial proportional-odds model. RESULTS: Of 15 569 registry patients with AIS or transient ischemic attack, 13 994 were included in the present analysis after exclusions (mean age, 73±12 years; 59.5% men). The RNF213 p.R4810K variant was identified in 359 patients (2.6%). ECAD was present in 2181 patients (15.6%), including 78 variant carriers. Variant carriers had significantly higher odds of ECAD after adjustment for vascular risk factors and ICAD (odds ratio, 1.69 [95% CI, 1.29-2.22]). This association was consistent irrespective of ICAD status (Pheterogeneity=0.32). In severity analyses, the association strengthened stepwise with increasing ECAD severity; the largest effect estimate was for occlusion (odds ratio, 4.55 [95% CI, 2.81-7.38]). CONCLUSIONS: The RNF213 p.R4810K variant was associated with ECAD independent of concomitant ICAD and showed a graded association with ECAD severity. Extracranial disease expression may involve modifiers distinct from those driving ICAD.
引用
- Takashima M, Kiyohara T, Nakamura K, et al. Independent Association of RNF213 p.R4810K With Extracranial Carotid Artery Disease Beyond Intracranial Atherosclerosis. Stroke. 2026. PMID: 42644243. doi:10.1161/STROKEAHA.126.055878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。